Involvement of histaminergic system in the anxiolytic-like activities of morus alba leaves in mice

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 11, 2013, Pages 1692-1699

  Lee, Seungheon ^a   Kim, Dong Hyun ^b   Lee, Ji Hye ^d   Ko, Eun Seong ^a   Oh, Won Bo ^a   Seo, Yong Taek ^c   Jang, Young Pyo ^c   Ryu, Jong Hoon ^c   Jung, Ji Wook ^d  

^a Jeju National University   (South Korea)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Kyung Hee University   (South Korea)

^d Daegu Haany University   (South Korea)

Author keywords

Anxiety; Elevated plus maze; Histamine; Morus alba; Thioperamide

Indexed keywords

DIAZEPAM; FLUMAZENIL; MESSENGER RNA; MULBERRY EXTRACT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; THIOPERAMIDE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; FALSE POSITIVE RESULT; HISTAMINERGIC SYSTEM; LOCOMOTION; MALE; MONOAMINERGIC SYSTEM; MORUS ALBA; MOUSE; MUSCLE RELAXATION; NONHUMAN; OPEN FIELD TEST; PLANT LEAF; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; FLUMAZENIL; GABA-A RECEPTOR ANTAGONISTS; HISTAMINE H3 ANTAGONISTS; HISTIDINE DECARBOXYLASE; MALE; MICE; MICE, INBRED ICR; MORUS; PIPERAZINES; PIPERIDINES; PLANT EXTRACTS; PLANT LEAVES; PYRIDINES; SEROTONIN ANTAGONISTS;

EID: 84888599060     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00126     Document Type: Article

References (51)

1. Asano N, Yamashita T, Yasuda K, Ikeda K, Kizu H, Kameda Y, Kato A, Nash RJ, Lee HS, Ryu KS. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem., 49, 4208-4213 (2001).
2. Hwang KH, Kim YK. Promoting effect and recovery activity from physical stress of the fruit of Morus alba. Biofactors, 21, 267-271 (2004).
3. Chen F, Nakashima N, Kimura I, Kimura M. Hypoglycemic activity and mechanisms of extracts from mulberry leaves (Folium mori) and Cortex mori radicis in streptozotocin-induced diabetic mice. Yakugaku Zasshi, 115, 476-482 (1995).
4. Jang MH, Kim H, Shin MC, Lim BV, Lee TH, Jung SB, Kim CJ, Kim EH. Administration of Folium mori extract decreases nitric oxide synthase expression in the hypothalamus of streptozotocininduced diabetic rats. Jpn. J. Pharmacol., 90, 189-192 (2002).
5. Ericson H, Watanabe T, Köhler C. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J. Comp. Neurol., 263, 1-24 (1987).
6. Oishi R, Nishibori M, Itoh Y, Saeki K. Diazepam-induced decrease in histamine turnover in mouse brain. Eur. J. Pharmacol., 124, 337-342 (1986).
7. Chikai T, Oishi R, Saeki K. Microdialysis study of the effects of sedative drugs on extracellular histamine in the striatum of freely moving rats. J. Pharmacol. Exp. Ther., 266, 1277-1281 (1993).
8. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L. (mulberry) leaves on anxiety in mice. Indian J. Pharmacol., 40, 32-36 (2008).
9. Yuzurihara M, Ikarashi Y, Ishige A, Sasaki H, Kuribara H, Maruyama Y. Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice. Pharmacol. Biochem. Behav., 67, 145-150 (2000).
10. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.), 92, 180-185 (1987).
11. Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav., 24, 525-529 (1986).
12. Commission CP. Pharmacopoeia of the People's Republic of China. Chemical Industry Press, Beijing (2005).
13. Jung JW, Cho JH, Ahn NY, Oh HR, Kim SY, Jang CG, Ryu JH. Effect of chronic Albizzia julibrissin treatment on 5-hydroxytryptamine1A receptors in rat brain. Pharmacol. Biochem. Behav., 81, 205-210 (2005).
14. Jung JW, Yoon BH, Oh HR, Ahn JH, Kim SY, Park SY, Ryu JH. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol. Pharm. Bull., 29, 261-265 (2006).
15. Pérez-Garcia C, Morales L, Cano MV, Sancho I, Alguacil LF. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression. Psychopharmacology (Berl.), 142, 215-220 (1999).
16. Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 350, 21-29 (1998).
17. Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Müller RK, Haefely W. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology (Berl.), 78, 8-18 (1982).
18. Fabene PF, Mariotti R, Navarro Mora G, Chakir A, Zancanaro C. Forced mild physical training-induced effects on cognitive and locomotory behavior in old mice. J. Nutr. Health Aging, 12, 388-390 (2008).
19. Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity Hum. Psychopharmacol., 16, 9-21 (2001).
20. Markov D, Goldman M. Normal sleep and circadian rhythms: neurobiologic mechanisms underlying sleep and wakefulness. Psychiatr. Clin. North Am., 29, 841-853, abstract, vii (2006).
21. Sakata T, Yoshimatsu H, Kurokawa M. Thermoregulation modulated by hypothalamic histamine in rats. Inflamm. Res., 46 (Suppl. 1), 35-36 (1997).
22. Malmberg-Aiello P, Ipponi A, Bartolini A, Schunack W. Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol. Biochem. Behav., 71, 313-318 (2002).
23. Rostami P, Hajizadeh-Moghaddam A, Zarrindast MR. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours. Physiol. Behav., 87, 891-896 (2006).
24. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature, 302, 832-837 (1983).
25. Vohora D, Pal SN, Pillai KK. Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice. Life Sci., 66, PL297-PL301 (2000).
26. Oishi R, Itoh Y, Saeki K. Inhibition of histamine turnover by 8-OHDPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain. Naunyn Schmiedebergs Arch. Pharmacol., 345, 495-499 (1992).
27. Atack J, Hallett DJ, Tye S, Wafford KA, Ryan C, Sanabria-Bohorquez S, Eng WS, Gibson RE, Burns HD, Dawson GR, Carling RW, Street LJ, Pike A, De Lepeleire I, Van Laere K, Bormans G, de Hoon JN, Van Hecken A, McKernan RM, Murphy MG, Hargreaves RJ. Preclinical and clinical pharmacology of TPA023B, a GABAA receptor a2/a3 subtype-selective partial agonis. J. Psychopharmacol., 25, 329-344 (2010).
28. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzas E, Kovacs P, Csaba G, Kittel A, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, Nagy A. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett., 502, 53-56 (2001).
29. Meguro K, Yanai K, Sakai N, Sakurai E, Maeyama K, Sasaki H, Watanabe T. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence- accelerated mice. Pharmacol. Biochem. Behav., 50, 321-325 (1995).
30. Ohtsu H, Watanabe T. New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem. Biophys. Res. Commun., 305, 443-447 (2003).
31. Watanabe T, Yamatodani A, Maeyama K, Wada H. Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends Pharmacol. Sci., 11, 363-367 (1990).
32. Cacabelos R, Alvarez XA. Histidine decarboxylase inhibition induced by alpha-fluoromethylhistidine provokes learning-related hypokinetic activity. Agents Actions, 33, 131-134 (1991).
33. Abe H, Honma S, Ohtsu H, Honma K. Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase. Brain Res. Mol. Brain Res., 124, 178-187 (2004).
34. Dere E, De Souza-Silva MA, Spieler RE, Lin JS, Ohtsu H, Haas HL, Huston JP. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur. J. Neurosci., 20, 1051-1058 (2004).
35. Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RG, Lacey SW. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. Proc. Natl. Acad. Sci. U.S.A., 89, 6006-6009 (1992).
36. Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW. Behavioral characterization of mice lacking histamine H3 receptors. Mol. Pharmacol., 62, 389-397 (2002).
37. Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl.), 100, 558-559 (1990).
38. Vaidya AH, Rosenthal DI, Lang W, Crooke JJ, Benjamin D, Ilyin SE, Reitz AB. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Methods Find. Exp. Clin. Pharmacol., 27, 245- 255 (2005).
39. Li YF, Gong ZH, Cao JB, Wang HL, Luo ZP, Li J. Antidepressantlike effect of agmatine and its possible mechanism. Eur. J. Pharmacol., 469, 81-88 (2003).
40. Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport, 13, 387-391 (2002).
41. Eckeli AL, Dach F, Rodrigues AL. Acute treatments with GMP produce antidepressant-like effects in mice. Neuroreport, 11, 1839- 1843 (2000).
42. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol., 92, 1-21 (2004).
43. Hirayama C, Ono H, Tamura Y, Konno K, Nakamura M. Regioselective formation of quercetin 5-O-glucoside from orally administered quercetin in the silkworm, Bombyx mori. Phytochemistry, 69, 1141-1149 (2008).
44. Kahraman A, Erkasap N, Koken T, Serteser M, Aktepe F, Erkasap S. The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions. Toxicology, 183, 133-142 (2003).
45. Lader M, Morton S. Benzodiazepine problems. Br. J. Addict., 86, 823-828 (1991).
46. Carlini EA. Plants and the central nervous system. Pharmacol. Biochem. Behav., 75, 501-512 (2003).
47. Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr. Serv., 51, 1130-1134 (2000).
48. Desai AK, Grossberg GT. Herbas and botanicals in geriatric psychiatry. Am. J. Geriat. Psychiatry, 11, 498-506 (2003).
49. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom. Med., 61, 712-728 (1999).
50. Lake J. Psychotropic medications from natural products: A review of promising research and recommendations. Altern. Ther. Health Med., 6, 36-52 (2000).
51. Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic reviews of herbal medicines - an annotated bibliography. Forschende Komplementarmedizin und klassische Naturheilkunde (Research in complementary and natural classical medicine), 10 (Suppl. 1), 17-27 (2003).